New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export ABBV’s income statement to Excel — free account
AbbVie Inc.
ABBVHealthcare Drug Manufacturers General
AbbVie Inc.’s revenue for fiscal 2025 (year ended December 2025) was $61.2 billion, up 8.57% from fiscal 2024.
- Revenue
- +10.3%
- EPS
- +2,270.0%
- Free cash flow
- +9.97%
- Total debt
- +17.7%
Quarter to September 2026, against a year earlier
288.73
5.22
+1.84%
Follow ABBV
Alert me
Where the cash went Fiscal 2025, year to Dec 31, 2025
Free cash flow of $17.8B covered $12.5B of dividends and buybacks. Cash fell by $295.0M. What is a cash flow statement?
- Free cash flow
- $17.8B 93.6% of operating cash flow
- Returned to shareholders
- $12.5B 70.0% of free cash flow
- Debt, net
- −$304.0M repaid
- Change in cash
- −$295.0M over the period
| Operating cash flow | 19.0 |
|---|---|
| Capital expenditures | −1.2 |
| Free cash flow | 17.8 |
| Acquisitions, net | −5.4 |
| From investments, net | 0.0 |
| Dividends | −11.7 |
| Buybacks, net | −0.8 |
| Debt repaid, net | −0.3 |
| Other | +0.1 |
| Change in cash | −0.3 |
Free cash flow
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.0B | $10.0B | $13.4B | $13.3B | $17.6B | $22.8B | $24.9B | $22.8B | $18.8B | $19.0B |
| Capex | −$479M | −$529M | −$638M | −$552M | −$798M | −$787M | −$695M | −$777M | −$974M | −$1.2B |
| Free cash flow | $6.6B | $9.4B | $12.8B | $12.8B | $16.8B | $22.0B | $24.2B | $22.1B | $17.8B | $17.8B |
Figures in billions of dollars. Free cash flow is operating cash flow less capital expenditures. Investments are purchases less sales of securities; “Other” is what the named lines leave of the change in cash.
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income |
5,953.00 | 5,309.00 | 5,687.00 | 7,882.00 | 4,622.00 | 11,549.00 | 11,845.00 | 4,873.00 | 4,286.00 | 4,233.00 |
Depreciation & Amortization |
1,189.00 | 1,501.00 | 1,765.00 | 2,017.00 | 6,471.00 | 8,521.00 | 8,467.00 | 12,927.00 | 12,862.00 | 8,986.00 |
Non Cash Items (Other) |
1,198.00 | 3,057.00 | 5,508.00 | 4,833.00 | 5,526.00 | 4,151.00 | 4,875.00 | 2,451.00 | 4,503.00 | 8,176.00 |
Accounts Receivable Change |
(71.00) | (391.00) | (591.00) | (74.00) | (929.00) | (1,321.00) | (1,455.00) | 66.00 | 207.00 | (1,490.00) |
Change in inventories |
(38.00) | 93.00 | (226.00) | (231.00) | (40.00) | (142.00) | (686.00) | (417.00) | (319.00) | (234.00) |
Accounts Payable Change |
(1,187.00) | 425.00 | 734.00 | 97.00 | 1,514.00 | 1,719.00 | 1,769.00 | 3,840.00 | 177.00 | 951.00 |
Income tax paid |
— | — | 674.00 | (1,018.00) | (573.00) | (1,290.00) | 542.00 | (488.00) | (3,208.00) | (762.00) |
Change in other assets and liabilities |
(3.00) | (34.00) | (124.00) | (182.00) | 997.00 | (410.00) | (414.00) | (413.00) | 298.00 | (830.00) |
Operating Cash Flow |
7,041.00 | 9,960.00 | 13,427.00 | 13,324.00 | 17,588.00 | 22,777.00 | 24,943.00 | 22,839.00 | 18,806.00 | 19,030.00 |
Capital expenditures |
(479.00) | (529.00) | (638.00) | (552.00) | (798.00) | (787.00) | (695.00) | (777.00) | (974.00) | (1,214.00) |
Net Aquisitions |
(2,757.00) | (308.00) | (736.00) | (1,135.00) | (39,610.00) | (1,902.00) | (794.00) | (1,223.00) | (20,517.00) | (5,441.00) |
Long-Term Investments Change (Net) |
(2,956.00) | 563.00 | 368.00 | 2,116.00 | 1,464.00 | (21.00) | 92.00 | (22.00) | 482.00 | 41.00 |
Other investing activities |
118.00 | (555.00) | (800.00) | 167.00 | 1,387.00 | 366.00 | 774.00 | 13.00 | 189.00 | (29.00) |
Investing cash flow |
(6,074.00) | (274.00) | (1,006.00) | 596.00 | (37,557.00) | (2,344.00) | (623.00) | (2,009.00) | (20,820.00) | (6,643.00) |
Repayment/Issuance of Debt (Net) |
5,594.00 | (2.00) | 3,229.00 | 26,247.00 | (2,683.00) | (8,414.00) | (12,433.00) | (4,149.00) | 7,350.00 | (304.00) |
Equity Repurchase (Common, Net) |
(5,765.00) | (1,156.00) | (11,941.00) | (621.00) | (769.00) | (690.00) | (1,225.00) | (1,792.00) | (1,494.00) | (808.00) |
Dividends Paid (Total) |
(3,717.00) | (4,107.00) | (5,580.00) | (6,366.00) | (7,716.00) | (9,261.00) | (10,043.00) | (10,539.00) | (11,025.00) | (11,657.00) |
Other financial activities |
(40.00) | (247.00) | (104.00) | (552.00) | (333.00) | (674.00) | (1,102.00) | (742.00) | (42.00) | 45.00 |
Financing cash flow |
(3,928.00) | (5,512.00) | (14,396.00) | 18,708.00 | (11,501.00) | (19,039.00) | (24,803.00) | (17,222.00) | (5,211.00) | (12,724.00) |
Exchange Rate Adjustment |
(338.00) | 29.00 | (39.00) | 7.00 | (5.00) | (97.00) | (62.00) | 5.00 | (65.00) | 42.00 |
Change in Cash |
(3,299.00) | 4,203.00 | (2,014.00) | 32,635.00 | (31,475.00) | 1,297.00 | (545.00) | 3,613.00 | (7,290.00) | (295.00) |
Beginning Cash |
8,399.00 | 5,100.00 | 9,303.00 | 7,289.00 | 39,924.00 | 8,449.00 | 9,746.00 | 9,201.00 | 12,814.00 | 5,524.00 |
Ending Cash |
5,100.00 | 9,303.00 | 7,289.00 | 39,924.00 | 8,449.00 | 9,746.00 | 9,201.00 | 12,814.00 | 5,524.00 | 5,229.00 |
Stock Based Compensation |
353.00 | 365.00 | 421.00 | 430.00 | 753.00 | 692.00 | 671.00 | 747.00 | 911.00 | 955.00 |
Dividends Paid (Common) |
(3,717.00) | (4,107.00) | (5,580.00) | (6,366.00) | (7,716.00) | (9,261.00) | (10,043.00) | (10,539.00) | (11,025.00) | (11,657.00) |
Net Cash/Marketcap |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Assets Liabilities Change (Total) |
(1,299.00) | 93.00 | 467.00 | (1,408.00) | 969.00 | (1,444.00) | (244.00) | 2,588.00 | (2,845.00) | (2,365.00) |
Investments Change (Net) |
(2,956.00) | 563.00 | 368.00 | 2,116.00 | 1,464.00 | (21.00) | 92.00 | (22.00) | 482.00 | 41.00 |
Issuance/Purchase of Shares |
(5,765.00) | (1,156.00) | (11,941.00) | (621.00) | (769.00) | (690.00) | (1,225.00) | (1,792.00) | (1,494.00) | (808.00) |
| Other line items | ||||||||||
Revenue per Employee |
0.85 | 0.97 | 1.09 | 1.11 | 0.97 | 1.12 | 1.16 | 1.09 | 1.02 | 1.07 |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026